Allison Eckard to Anti-HIV Agents
This is a "connection" page, showing publications Allison Eckard has written about Anti-HIV Agents.
Connection Strength
1.880
-
Contemporary Issues in Pregnancy (and Offspring) in the Current HIV Era. Curr HIV/AIDS Rep. 2019 12; 16(6):492-500.
Score: 0.614
-
Complications of Treatment in Youth with HIV. Curr HIV/AIDS Rep. 2016 08; 13(4):226-33.
Score: 0.487
-
Weight gain and integrase inhibitors. Curr Opin Infect Dis. 2020 02; 33(1):10-19.
Score: 0.155
-
Effects of Vitamin D Supplementation on Bone Mineral Density and Bone Markers in HIV-Infected Youth. J Acquir Immune Defic Syndr. 2017 12 15; 76(5):539-546.
Score: 0.134
-
Arterial stiffness in HIV-infected youth and associations with HIV-related variables. Virulence. 2017 10 03; 8(7):1265-1273.
Score: 0.127
-
Efavirenz and ritonavir-boosted lopinavir use exhibited elevated markers of atherosclerosis across age groups in people living with HIV in Ethiopia. J Biomech. 2016 09 06; 49(13):2584-2592.
Score: 0.120
-
The role of statins in the setting of HIV infection. Curr HIV/AIDS Rep. 2015 Sep; 12(3):305-12.
Score: 0.114
-
Metabolic complications and treatment of perinatally HIV-infected children and adolescents. J Int AIDS Soc. 2013 Jun 18; 16:18600.
Score: 0.098
-
Bone loss in HIV: a contemporary review. Curr Opin Endocrinol Diabetes Obes. 2015 Dec; 22(6):446-51.
Score: 0.029